How Peptides Are Made: Synthesis, Purification, and Quality

Modern peptide manufacturing is a sophisticated chemical process that combines automated synthesis, advanced purification, and rigorous analytical testing. Understanding how peptides are made helps contextualize purity claims, evaluate quality documentation, and appreciate why peptide quality varies significantly between sources.

Solid-Phase Peptide Synthesis (SPPS)

The dominant method for producing synthetic peptides is solid-phase peptide synthesis (SPPS), a technique pioneered by Robert Bruce Merrifield in 1963 — work for which he received the Nobel Prize in Chemistry in 1984 Merrifield, 1963.

Before Merrifield's innovation, peptides were synthesized in solution — a laborious process requiring purification after every amino acid addition. Merrifield's breakthrough was anchoring the growing peptide chain to an insoluble resin bead, allowing excess reagents and byproducts to be washed away simply by filtering. This made peptide synthesis faster, more reliable, and amenable to automation.

The Merrifield Method: Core Principles

SPPS builds a peptide chain one amino acid at a time, from the C-terminus to the N-terminus (the reverse of biological protein synthesis, which proceeds N-to-C). The peptide remains attached to the resin throughout synthesis and is only cleaved off at the end.

Two major chemical strategies exist:

• Boc (tert-butyloxycarbonyl) chemistry — Merrifield's original approach. Uses strong acid (hydrofluoric acid) for final cleavage. Largely superseded for routine synthesis due to handling hazards.
• Fmoc (9-fluorenylmethyloxycarbonyl) chemistry — The modern standard. Uses mild base (piperidine) for deprotection and milder acids (TFA) for final cleavage. More compatible with automated synthesizers and sensitive amino acids Carpino & Han, 1972.

Step-by-Step Synthesis Process (Fmoc SPPS)

1. Resin selection and loading — A cross-linked polystyrene or polyethylene glycol resin is chosen based on the desired C-terminal functionality. The first amino acid (the C-terminal residue) is attached to the resin through a cleavable linker.

2. Fmoc deprotection — The Fmoc protecting group on the alpha-amino group of the resin-bound amino acid is removed using a solution of 20% piperidine in DMF (dimethylformamide). This exposes the free amino group for the next coupling.

3. Washing — The resin is washed thoroughly with DMF and/or dichloromethane to remove piperidine and the cleaved Fmoc group (dibenzofulvene).

4. Amino acid activation — The next amino acid in the sequence (still bearing its own Fmoc protecting group) is activated using a coupling reagent such as HBTU, HATU, or DIC/HOBt. Activation converts the carboxyl group into a more reactive form.

5. Coupling reaction — The activated amino acid is added to the resin. It reacts with the free amino group of the resin-bound peptide, forming a new peptide bond. This reaction typically achieves >99% efficiency per cycle.

6. Washing — Excess reagents and byproducts are washed away.

7. Repeat steps 2–6 — The deprotection-coupling cycle is repeated for each amino acid in the sequence, building the chain one residue at a time from C-terminus to N-terminus.

8. Final deprotection — After the last amino acid is coupled, the final Fmoc group is removed.

9. Side-chain deprotection and cleavage — The completed peptide is cleaved from the resin using a cleavage cocktail, typically 95% trifluoroacetic acid (TFA) with scavengers (water, triisopropylsilane, ethanedithiol) to prevent side reactions. This step also removes all side-chain protecting groups simultaneously.

10. Precipitation and initial recovery — The crude peptide is precipitated by adding cold diethyl ether, collected by centrifugation, and dissolved for purification.

Yield considerations: Even at 99.5% coupling efficiency per step, a 30-residue peptide would have a theoretical crude yield of only ~86% (0.995^30). For longer peptides, yields decrease further, which is why peptides longer than ~50 amino acids are often produced by fragment condensation or recombinant expression rather than straightforward SPPS.

Common Challenges in Synthesis

• Aggregation — Hydrophobic sequences can aggregate on the resin, reducing coupling efficiency. Pseudoproline dipeptides and backbone-protecting groups help mitigate this Mutter et al., 2004.
• Racemization — Activation can cause chiral inversion at the alpha-carbon. Histidine and cysteine are particularly susceptible. Modern coupling reagents like HATU minimize this risk.
• Aspartimide formation — Asp residues can cyclize during piperidine treatment, generating undesirable byproducts. Backbone protection or modified deprotection conditions can prevent this.
• Difficult sequences — Poly-alanine, poly-valine, and other repetitive hydrophobic sequences are notoriously difficult to synthesize due to on-resin aggregation.

HPLC Purification

After cleavage from the resin, the crude peptide is a mixture of the desired product plus deletion sequences (missing one or more amino acids), truncated sequences, and other impurities. High-performance liquid chromatography (HPLC) is the standard method for purifying peptides to research or pharmaceutical grade.

How HPLC Works

Reversed-phase HPLC (RP-HPLC) is the most common mode for peptide purification:

1. The crude peptide mixture is dissolved and injected onto a C18 or C8 column — a tube packed with silica particles coated with hydrophobic alkyl chains.
2. A gradient of increasing organic solvent (typically acetonitrile) in water with 0.1% TFA is pumped through the column.
3. Peptide components interact differently with the hydrophobic stationary phase based on their hydrophobicity. More hydrophobic species are retained longer.
4. Components elute at different times, detected by UV absorbance at 214 nm (peptide bond absorption) or 280 nm (aromatic amino acids).
5. The fraction containing the target peptide is collected, and the organic solvent is removed by lyophilization (freeze-drying).

What "99% Purity" Means

When a peptide is described as "99% pure by HPLC," this means that the target peptide peak constitutes 99% of the total integrated peak area on the HPLC chromatogram. This metric has important nuances:

• HPLC purity measures chromatographic purity — it tells you that 99% of the UV-absorbing material eluting from the column is the target compound.
• It does not account for non-UV-absorbing impurities such as residual salts, TFA counterions, or water content. A peptide that is "99% pure by HPLC" might be only 70–80% peptide content by weight due to counterions and moisture.
• Net peptide content is a separate measurement, typically determined by amino acid analysis or nitrogen content analysis.

Quality Evaluation

Certificate of Analysis (COA)

A COA is a document provided by the manufacturer that reports the results of quality control testing for a specific batch of peptide. A comprehensive COA should include:

• Peptide sequence — Confirmed amino acid sequence
• Molecular weight — Observed vs. theoretical
• HPLC purity — Chromatogram with retention time and purity percentage
• Mass spectrometry data — Observed molecular ion vs. expected mass
• Appearance — Physical description (typically white to off-white lyophilized powder)
• Net peptide content — Actual peptide weight as a percentage of total weight
• Counterion — Usually TFA or acetate salt form
• Batch/lot number — For traceability

Mass Spectrometry Confirmation

Mass spectrometry (MS) is the gold standard for confirming peptide identity. The two most common techniques are:

MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization - Time of Flight) — Fast, sensitive, and ideal for confirming molecular weight. A peptide is co-crystallized with a UV-absorbing matrix, ionized by a laser pulse, and the time of flight through a vacuum tube determines its mass-to-charge ratio Karas & Hillenkamp, 1988.

ESI-MS (Electrospray Ionization Mass Spectrometry) — Produces multiply charged ions, making it suitable for larger peptides. Often coupled with LC (LC-MS) for simultaneous purification and identification.

The observed mass should match the theoretical mass within the instrument's accuracy (typically within 0.1% for MALDI-TOF and 0.01% for high-resolution ESI).

Evaluating a Supplier

When assessing peptide quality from a research perspective, consider the following:

• Batch-specific COA availability — Every lot should have its own COA, not a generic template. Request the COA before accepting any product.
• Third-party testing — Independent analytical verification provides an additional layer of confidence beyond the manufacturer's own testing.
• Mass spectrometry data — The COA should include an actual mass spectrum (not just a reported number) showing the molecular ion peak matching the expected mass.
• HPLC chromatogram — Look for a clean, single major peak. Multiple peaks of significant size indicate impurities or degradation.
• Consistent appearance — Lyophilized peptides should be a uniform powder, not clumped, discolored, or crystalline (which may indicate residual solvent).
• Proper storage and shipping — Peptides should be shipped on dry ice or cold packs and stored at -20 C or below to prevent degradation Manning et al., 2010.

Alternative Production Methods

While SPPS dominates for peptides under ~50 amino acids, other methods are used for specific applications:

• Recombinant expression — Larger peptides and proteins (e.g., insulin, HGH) are produced in bacteria (E. coli), yeast, or mammalian cells using recombinant DNA technology. This is more cost-effective for large-scale production of peptides over ~30–40 amino acids.
• Enzymatic synthesis — Proteases can be used in reverse to catalyze peptide bond formation under specific conditions. Useful for short peptides and peptides with unusual modifications.
• Chemical ligation — Techniques like native chemical ligation (NCL) allow two unprotected peptide fragments to be joined in aqueous solution, enabling synthesis of proteins up to 200+ amino acids Dawson et al., 1994.

Further Reading

• Peptide Basics — Foundational concepts on peptide structure and function
• Peptide Bonds — Detailed chemistry of the peptide bond
• Peptide Purification — Additional depth on purification methods
• Peptide Storage — Best practices for maintaining peptide stability